Literature DB >> 24890697

Analytical challenges translating mass spectrometry-based phosphoproteomics from discovery to clinical applications.

Anton B Iliuk1, Justine V Arrington, Weiguo Andy Tao.   

Abstract

Phosphoproteomics is the systematic study of one of the most common protein modifications in high throughput with the aim of providing detailed information of the control, response, and communication of biological systems in health and disease. Advances in analytical technologies and strategies, in particular the contributions of high-resolution mass spectrometers, efficient enrichments of phosphopeptides, and fast data acquisition and annotation, have catalyzed dramatic expansion of signaling landscapes in multiple systems during the past decade. While phosphoproteomics is an essential inquiry to map high-resolution signaling networks and to find relevant events among the apparently ubiquitous and widespread modifications of proteome, it presents tremendous challenges in separation sciences to translate it from discovery to clinical practice. In this mini-review, we summarize the analytical tools currently utilized for phosphoproteomic analysis (with focus on MS), progresses made on deciphering clinically relevant kinase-substrate networks, MS uses for biomarker discovery and validation, and the potential of phosphoproteomics for disease diagnostics and personalized medicine.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Kinase; MS; Phosphoproteomics

Mesh:

Substances:

Year:  2014        PMID: 24890697      PMCID: PMC4250476          DOI: 10.1002/elps.201400153

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  175 in total

1.  Interlaboratory evaluation of automated, multiplexed peptide immunoaffinity enrichment coupled to multiple reaction monitoring mass spectrometry for quantifying proteins in plasma.

Authors:  Eric Kuhn; Jeffrey R Whiteaker; D R Mani; Angela M Jackson; Lei Zhao; Matthew E Pope; Derek Smith; Keith D Rivera; N Leigh Anderson; Steven J Skates; Terry W Pearson; Amanda G Paulovich; Steven A Carr
Journal:  Mol Cell Proteomics       Date:  2011-12-22       Impact factor: 5.911

2.  Addressing accuracy and precision issues in iTRAQ quantitation.

Authors:  Natasha A Karp; Wolfgang Huber; Pawel G Sadowski; Philip D Charles; Svenja V Hester; Kathryn S Lilley
Journal:  Mol Cell Proteomics       Date:  2010-04-10       Impact factor: 5.911

3.  Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.

Authors:  John Rush; Albrecht Moritz; Kimberly A Lee; Ailan Guo; Valerie L Goss; Erik J Spek; Hui Zhang; Xiang-Ming Zha; Roberto D Polakiewicz; Michael J Comb
Journal:  Nat Biotechnol       Date:  2004-12-12       Impact factor: 54.908

4.  SIMAC (sequential elution from IMAC), a phosphoproteomics strategy for the rapid separation of monophosphorylated from multiply phosphorylated peptides.

Authors:  Tine E Thingholm; Ole N Jensen; Phillip J Robinson; Martin R Larsen
Journal:  Mol Cell Proteomics       Date:  2007-11-26       Impact factor: 5.911

5.  Online automated in vivo zebrafish phosphoproteomics: from large-scale analysis down to a single embryo.

Authors:  Simone Lemeer; Martijn W H Pinkse; Shabaz Mohammed; Bas van Breukelen; Jeroen den Hertog; Monique Slijper; Albert J R Heck
Journal:  J Proteome Res       Date:  2008-02-29       Impact factor: 4.466

Review 6.  Quantitative phospho-proteomics based on soluble nanopolymers.

Authors:  Anton Iliuk; W Andy Tao
Journal:  Methods Mol Biol       Date:  2009

Review 7.  Phosphoproteomics in drug discovery.

Authors:  Melody K Morris; An Chi; Ioannis N Melas; Leonidas G Alexopoulos
Journal:  Drug Discov Today       Date:  2013-10-18       Impact factor: 7.851

8.  Quantitative phosphoproteomics applied to the yeast pheromone signaling pathway.

Authors:  Albrecht Gruhler; Jesper V Olsen; Shabaz Mohammed; Peter Mortensen; Nils J Faergeman; Matthias Mann; Ole N Jensen
Journal:  Mol Cell Proteomics       Date:  2005-01-22       Impact factor: 5.911

9.  Comparison of ERLIC-TiO2, HILIC-TiO2, and SCX-TiO2 for global phosphoproteomics approaches.

Authors:  Mostafa Zarei; Adrian Sprenger; Fabian Metzger; Christine Gretzmeier; Joern Dengjel
Journal:  J Proteome Res       Date:  2011-07-08       Impact factor: 4.466

10.  In vivo SILAC-based proteomics reveals phosphoproteome changes during mouse skin carcinogenesis.

Authors:  Sara Zanivan; Alexander Meves; Kristina Behrendt; Erwin M Schoof; Lisa J Neilson; Jürgen Cox; Hao R Tang; Gabriela Kalna; Janine H van Ree; Jan M van Deursen; Carol S Trempus; Laura M Machesky; Rune Linding; Sara A Wickström; Reinhard Fässler; Matthias Mann
Journal:  Cell Rep       Date:  2013-01-31       Impact factor: 9.423

View more
  9 in total

1.  Phosphoproteins in extracellular vesicles as candidate markers for breast cancer.

Authors:  I-Hsuan Chen; Liang Xue; Chuan-Chih Hsu; Juan Sebastian Paez Paez; Li Pan; Hillary Andaluz; Michael K Wendt; Anton B Iliuk; Jian-Kang Zhu; W Andy Tao
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-07       Impact factor: 11.205

2.  Estimating the Efficiency of Phosphopeptide Identification by Tandem Mass Spectrometry.

Authors:  Chuan-Chih Hsu; Liang Xue; Justine V Arrington; Pengcheng Wang; Juan Sebastian Paez Paez; Yuan Zhou; Jian-Kang Zhu; W Andy Tao
Journal:  J Am Soc Mass Spectrom       Date:  2017-03-10       Impact factor: 3.109

Review 3.  Recent advances in phosphoproteomics and application to neurological diseases.

Authors:  Justine V Arrington; Chuan-Chih Hsu; Sarah G Elder; W Andy Tao
Journal:  Analyst       Date:  2017-11-20       Impact factor: 4.616

4.  Automated Nanoflow Two-Dimensional Reversed-Phase Liquid Chromatography System Enables In-Depth Proteome and Phosphoproteome Profiling of Nanoscale Samples.

Authors:  Maowei Dou; Chia-Feng Tsai; Paul D Piehowski; Yang Wang; Thomas L Fillmore; Rui Zhao; Ronald J Moore; Pengfei Zhang; Wei-Jun Qian; Richard D Smith; Tao Liu; Ryan T Kelly; Tujin Shi; Ying Zhu
Journal:  Anal Chem       Date:  2019-07-09       Impact factor: 6.986

Review 5.  Emerging roles of exosome-derived biomarkers in cancer theranostics: messages from novel protein targets.

Authors:  Jiongjia Cheng; Xiaofeng Wang; Xuechun Yuan; Guangxiang Liu; Qian Chu
Journal:  Am J Cancer Res       Date:  2022-05-15       Impact factor: 5.942

6.  Tissue phosphoproteomics with PolyMAC identifies potential therapeutic targets in a transgenic mouse model of HER2 positive breast cancer.

Authors:  Adam C Searleman; Anton B Iliuk; Timothy S Collier; Lewis A Chodosh; W Andy Tao; Ron Bose
Journal:  Electrophoresis       Date:  2014-06-12       Impact factor: 3.535

Review 7.  Exosomal proteins as potential markers of tumor diagnosis.

Authors:  Aichun Li; Tianbao Zhang; Min Zheng; Yanning Liu; Zhi Chen
Journal:  J Hematol Oncol       Date:  2017-12-27       Impact factor: 17.388

8.  A circulating extracellular vesicles-based novel screening tool for colorectal cancer revealed by shotgun and data-independent acquisition mass spectrometry.

Authors:  Xi Zheng; Kailun Xu; Biting Zhou; Ting Chen; Yanqin Huang; Qilong Li; Fei Wen; Weiting Ge; Jian Wang; Shaojun Yu; Lifeng Sun; Liang Zhu; Wei Liu; Huanhuan Gao; Liang Yue; Xue Cai; Qiushi Zhang; Guan Ruan; Tiansheng Zhu; Zhicheng Wu; Yi Zhu; Yingkuan Shao; Tiannan Guo; Shu Zheng
Journal:  J Extracell Vesicles       Date:  2020-04-14

Review 9.  Urinary proteomics and metabolomics studies to monitor bladder health and urological diseases.

Authors:  Zhaohui Chen; Jayoung Kim
Journal:  BMC Urol       Date:  2016-03-22       Impact factor: 2.264

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.